Similar articles for PMID: 25210463

Year	Number of Results
2007	1
2008	1
2009	2
2010	9
2011	7
2012	12
2013	9
2014	16
2015	15
2016	12
2017	9
2018	3
2019	5
2020	6
2021	1
2022	1

1

The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis.

Ying HQ, Wang F, He BS, Pan YQ, Gao TY, Xu YQ, Li R, Deng QW, Sun HL, Wang SK. Ying HQ, et al. Onco Targets Ther. 2014 Aug 25;7:1487-96. doi: 10.2147/OTT.S65496. eCollection 2014. Onco Targets Ther. 2014. PMID: 25210463 Free PMC article.

2

rs61764370 polymorphism of Kras and risk of cancer in Caucasian population: A meta-analysis.

Zhang SY, Shi J. Zhang SY, et al. J Cancer Res Ther. 2016 Apr-Jun;12(2):699-704. doi: 10.4103/0973-1482.147379. J Cancer Res Ther. 2016. PMID: 27461636 Free article.

3

Association of rs712 polymorphism in Kras gene 3'-luntranslated region and cancer risk: a meta-analysis.

Zhao WH, Qu XF, Xing ZG, Zhao LQ, Qin L, Lv C. Zhao WH, et al. J BUON. 2015 Jan-Feb;20(1):309-16. J BUON. 2015. PMID: 25778332 Free article. Review.

4

Association of rs712 polymorphism in a let-7 microRNA-binding site of KRAS gene with colorectal cancer in a Mexican population.

Gallegos-Arreola MP, Zúñiga-González GM, Gómez-Mariscal K, Rosales-Reynoso MA, Luis L, Puebla-Pérez AM, Pineda-Razo T. Gallegos-Arreola MP, et al. Iran J Basic Med Sci. 2019 Mar;22(3):324-327. doi: 10.22038/ijbms.2019.26564.6507. Iran J Basic Med Sci. 2019. PMID: 31156795 Free PMC article.

5

rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese population.

Jiang QH, Peng HX, Zhang Y, Tian P, Xi ZL, Chen H. Jiang QH, et al. Onco Targets Ther. 2015 Oct 22;8:3041-5. doi: 10.2147/OTT.S89746. eCollection 2015. Onco Targets Ther. 2015. PMID: 26543374 Free PMC article.

6

Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population.

Gallegos-Arreola MP, García Verdín PM, Magaña-Torres MT, Figuera LE, Zúñiga-González GM, Rosales-Reynoso MA, Gómez-Meda BC, Puebla-Pérez AM. Gallegos-Arreola MP, et al. Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6454-6464. doi: 10.26355/eurrev_202111_27088. Eur Rev Med Pharmacol Sci. 2021. PMID: 34787849 Free article.

7

Protective effect of rs712 polymorphism in a let-7 microRNA-binding of KRAS gene in breast cancer of a Mexican population.

Patricia Gallegos-Arreola M, Briseño Zuno CJ, Eduardo Figuera L, Zúñiga González GM, Perales Mederos CI, Puebla Pérez AM, Rosales Reynoso MA. Patricia Gallegos-Arreola M, et al. J BUON. 2020 Jan-Feb;25(1):176-181. J BUON. 2020. PMID: 32277629 Free article.

8

KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population.

Sanaei S, Hashemi M, Eskandari E, Hashemi SM, Bahari G. Sanaei S, et al. Asian Pac J Cancer Prev. 2017 May 1;18(5):1301-1305. doi: 10.22034/APJCP.2017.18.5.1301. Asian Pac J Cancer Prev. 2017. PMID: 28610418 Free PMC article.

9

A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.

Li ZH, Pan XM, Han BW, Guo XM, Zhang Z, Jia J, Gao LB. Li ZH, et al. Tumour Biol. 2013 Oct;34(5):3159-63. doi: 10.1007/s13277-013-0885-x. Epub 2013 Jun 2. Tumour Biol. 2013. PMID: 23729275

10

Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.

Huang X, Yang Y, Guo Y, Cao ZL, Cui ZW, Hu TC, Gao LB. Huang X, et al. Genet Mol Res. 2015 Dec 14;14(4):16913-20. doi: 10.4238/2015.December.14.19. Genet Mol Res. 2015. PMID: 26681038 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed